Insights

The medical implant industry is set to grow from $5bn in 2017 to $16.3bn by 2022. But there are tensions to understand and hurdles to overcome for innovators intent on taking advantage.

Patient monitoring is an inherent part of patient management. Intermittent and continuous measurements have a range of uses, from defining disease states and characterising progression to informing therapeutic approaches and...

Products are incorporating increasingly complex technology, putting greater pressure on the supply chain. As a result, gaps are forming and the risk to reputations and revenues is growing through issues such as...

Surgical robotics will have a prosperous short-term future, with most key players expected to introduce laparoscopic surgical robotic systems by 2020. By 2030, the convergence of several technology opportunities, including...

It was fantastic to win one of the coveted iF DESIGN AWARDS for Alma, our smart cooling case for injectable fertility drugs. International recognition was a nice boost to the team responsible for a concept with potential to improve quality of life for women facing the challenges of IVF treatment...

The future of non-contact monitoring: some novel devices which were presented at  CES 2020 for improving health and detecting disease conditions. Many of these were wearables; some are portable. A non-contact monitoring system developed at Cambridge Consultants is described, including a discussion of a range of areas where these technologies could be applied.

Our webinar reveals how device developers will need to maneuver through conservative, highly regulated, monopolistic yet fragmented healthcare systems that often provide contradictory incentives. Following the presentation, our audience had the opportunity to ask a variety of questions. Here’s what our experts had to say in reply.

In this talk, we explore some of the challenges and opportunities inherent to the adoption of remote monitoring, AI and wearables. We draw on our experience to demonstrate how the digital transformation of trials is possible with a collaborative approach between engineering, healthcare bodies and the pharmaceutical industry.

An aging population suffering from ever-more complex chronic conditions and concerns about health funding catching up, let alone keeping pace. If that’s the gloomy global state of healthcare in short-form, then many are pinning their hopes on home care – buoyed by the promise of remote patient monitoring – to provide the remedy.

With patients spending less time in hospital and more time at home or in long-term care establishments, the future is bright for medical bed manufacturers able to deliver the innovative solutions that are needed to successfully reshape healthcare delivery.

Consumer healthcare device or regulated medical device? The distinction is becoming more complex, fortunately there is FDA guidance on how to navigate these pathways

Cambridge Consultants recently brought together some of the brightest names and biggest companies in the medical device industry, to explore how surgical navigation can democratize surgery in the future and to envision the surgical navigation ecosystem of 2030.